Decibel Therapeutics DBTX
$ 4.91
0.0%
Quarterly report 2023-Q2
added 08-11-2023
Decibel Therapeutics Balance Sheet 2011-2024 | DBTX
Annual Balance Sheet Decibel Therapeutics
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-31 M | - | -27.1 M | -18.6 M | -11.3 M | - | - | - | - | - | - | - |
Long Term Debt |
19 K | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
3.57 M | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | 523 K | 17.5 M | 24.8 M | - | - | - | - | - | - | - |
Total Current Liabilities |
22.4 M | 20.5 M | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
41.6 M | 42.8 M | 230 M | 27 M | 35.8 M | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-278 M | -215 M | - | -123 M | -80.7 M | - | - | - | - | - | - | - |
Total Assets |
123 M | 184 M | 67.3 M | 42.8 M | 93.3 M | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
34.6 M | 36.5 M | - | - | - | - | - | - | - | - | - | - |
Book Value |
81.8 M | 142 M | -163 M | 15.8 M | 57.5 M | - | - | - | - | - | - | - |
Total Shareholders Equity |
81.8 M | 142 M | -54.8 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Decibel Therapeutics
2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
46 K | 9.81 M | 10.5 M | 11.1 M | 11.7 M | 12.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
41.1 M | 40.6 M | 41.6 M | 45.5 M | 46.4 M | 45.7 M | 42.8 M | 31.1 M | 27.5 M | 26.8 M | 29 M | 29 M | 29 M | 29 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-309 M | -291 M | -278 M | -262 M | -246 M | -229 M | -215 M | -202 M | -185 M | -174 M | -163 M | -163 M | -163 M | -163 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
94.4 M | 110 M | 123 M | 142 M | 158 M | 174 M | 184 M | 185 M | 197 M | 207 M | 67.3 M | 67.3 M | 67.3 M | 67.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
39.8 M | 38.1 M | 34.6 M | 36.7 M | 56.5 M | 10.8 M | 36.5 M | 51.4 M | 37.7 M | 52.2 M | 27.7 M | 27.7 M | 27.7 M | 27.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
53.3 M | 69.8 M | 81.8 M | 96.8 M | 112 M | 128 M | 142 M | 154 M | 169 M | 180 M | 38.3 M | 38.3 M | 38.3 M | 38.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
53.3 M | 69.8 M | 81.8 M | 96.8 M | 112 M | 128 M | 142 M | 154 M | 169 M | 180 M | -54.8 M | -54.8 M | -54.8 M | -54.8 M | -122 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency